| Product Code: ETC6359828 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Belgium Oncology NGS Market Overview |
3.1 Belgium Country Macro Economic Indicators |
3.2 Belgium Oncology NGS Market Revenues & Volume, 2021 & 2031F |
3.3 Belgium Oncology NGS Market - Industry Life Cycle |
3.4 Belgium Oncology NGS Market - Porter's Five Forces |
3.5 Belgium Oncology NGS Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 Belgium Oncology NGS Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Belgium Oncology NGS Market Revenues & Volume Share, By Service, 2021 & 2031F |
3.8 Belgium Oncology NGS Market Revenues & Volume Share, By Workflow, 2021 & 2031F |
3.9 Belgium Oncology NGS Market Revenues & Volume Share, By End-use, 2021 & 2031F |
4 Belgium Oncology NGS Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Belgium |
4.2.2 Growing demand for personalized medicine in oncology |
4.2.3 Technological advancements in next-generation sequencing (NGS) technologies |
4.2.4 Rising adoption of NGS for cancer diagnosis and treatment |
4.3 Market Restraints |
4.3.1 High cost associated with NGS testing |
4.3.2 Limited reimbursement policies for NGS-based oncology tests |
4.3.3 Data privacy and security concerns related to genomic data |
5 Belgium Oncology NGS Market Trends |
6 Belgium Oncology NGS Market, By Types |
6.1 Belgium Oncology NGS Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 Belgium Oncology NGS Market Revenues & Volume, By Technology, 2021- 2031F |
6.1.3 Belgium Oncology NGS Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.1.4 Belgium Oncology NGS Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.2 Belgium Oncology NGS Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Belgium Oncology NGS Market Revenues & Volume, By Diagnostics and Screening, 2021- 2031F |
6.2.3 Belgium Oncology NGS Market Revenues & Volume, By Research Studies, 2021- 2031F |
6.3 Belgium Oncology NGS Market, By Service |
6.3.1 Overview and Analysis |
6.3.2 Belgium Oncology NGS Market Revenues & Volume, By Platforms and Related Products, 2021- 2031F |
6.3.3 Belgium Oncology NGS Market Revenues & Volume, By Services, 2021- 2031F |
6.4 Belgium Oncology NGS Market, By Workflow |
6.4.1 Overview and Analysis |
6.4.2 Belgium Oncology NGS Market Revenues & Volume, By Pre-Sequencing, 2021- 2031F |
6.4.3 Belgium Oncology NGS Market Revenues & Volume, By Sequencing, 2021- 2031F |
6.4.4 Belgium Oncology NGS Market Revenues & Volume, By NGS Data Analysis, 2021- 2031F |
6.5 Belgium Oncology NGS Market, By End-use |
6.5.1 Overview and Analysis |
6.5.2 Belgium Oncology NGS Market Revenues & Volume, By Academic Research, 2021- 2031F |
6.5.3 Belgium Oncology NGS Market Revenues & Volume, By Clinical Research, 2021- 2031F |
6.5.4 Belgium Oncology NGS Market Revenues & Volume, By Hospitals & Clinics, 2021- 2031F |
6.5.5 Belgium Oncology NGS Market Revenues & Volume, By Pharma & Biotech Entities, 2021- 2031F |
6.5.6 Belgium Oncology NGS Market Revenues & Volume, By Other users, 2021- 2031F |
7 Belgium Oncology NGS Market Import-Export Trade Statistics |
7.1 Belgium Oncology NGS Market Export to Major Countries |
7.2 Belgium Oncology NGS Market Imports from Major Countries |
8 Belgium Oncology NGS Market Key Performance Indicators |
8.1 Average turnaround time for NGS testing in oncology |
8.2 Number of oncology clinics/hospitals adopting NGS technology |
8.3 Rate of adoption of NGS-based treatment plans by oncologists |
9 Belgium Oncology NGS Market - Opportunity Assessment |
9.1 Belgium Oncology NGS Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 Belgium Oncology NGS Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Belgium Oncology NGS Market Opportunity Assessment, By Service, 2021 & 2031F |
9.4 Belgium Oncology NGS Market Opportunity Assessment, By Workflow, 2021 & 2031F |
9.5 Belgium Oncology NGS Market Opportunity Assessment, By End-use, 2021 & 2031F |
10 Belgium Oncology NGS Market - Competitive Landscape |
10.1 Belgium Oncology NGS Market Revenue Share, By Companies, 2024 |
10.2 Belgium Oncology NGS Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here